CollPlant Biotechnologies Statistics Share Statistics CollPlant Biotechnologies has 12.72M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 12.72M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 0.03% Shares Floating 9.86M Failed to Deliver (FTD) Shares 13,869 FTD / Avg. Volume 11.25%
Short Selling Information The latest short interest is 126.05K, so 0.99% of the outstanding
shares have been sold short.
Short Interest 126.05K Short % of Shares Out 0.99% Short % of Float 1.41% Short Ratio (days to cover) 1.63
Valuation Ratios The PE ratio is -2.48 and the forward
PE ratio is 286.
CollPlant Biotechnologies's PEG ratio is
-0.02.
PE Ratio -2.48 Forward PE 286 PS Ratio 80.07 Forward PS 2.1 PB Ratio 3.06 P/FCF Ratio -2.83 PEG Ratio -0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for CollPlant Biotechnologies.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.44,
with a Debt / Equity ratio of 0.23.
Current Ratio 4.44 Quick Ratio 4.29 Debt / Equity 0.23 Debt / EBITDA -0.19 Debt / FCF -0.21 Interest Coverage -1014.76
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $9.04K Profits Per Employee $-291.39K Employee Count 57 Asset Turnover 0.03 Inventory Turnover 3.69
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -33.03% in the
last 52 weeks. The beta is 0.78, so CollPlant Biotechnologies's
price volatility has been higher than the market average.
Beta 0.78 52-Week Price Change -33.03% 50-Day Moving Average 1.97 200-Day Moving Average 2.96 Relative Strength Index (RSI) 71.56 Average Volume (20 Days) 123,241
Income Statement In the last 12 months, CollPlant Biotechnologies had revenue of 515K
and earned -16.61M
in profits. Earnings per share was -1.45.
Revenue 515K Gross Profit -1.11M Operating Income -17.25M Net Income -16.61M EBITDA -16.21M EBIT -17.25M Earnings Per Share (EPS) -1.45
Full Income Statement Balance Sheet The company has 11.91M in cash and 3.08M in
debt, giving a net cash position of 8.83M.
Cash & Cash Equivalents 11.91M Total Debt 3.08M Net Cash 8.83M Retained Earnings -113.35M Total Assets 17.21M Working Capital 9.39M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -14.09M
and capital expenditures -483K, giving a free cash flow of -14.58M.
Operating Cash Flow -14.09M Capital Expenditures -483K Free Cash Flow -14.58M FCF Per Share -1.27
Full Cash Flow Statement Margins Gross margin is -215.53%, with operating and profit margins of -3349.71% and -3225.05%.
Gross Margin -215.53% Operating Margin -3349.71% Pretax Margin -3225.05% Profit Margin -3225.05% EBITDA Margin -3148.16% EBIT Margin -3349.71% FCF Margin -2830.29%
Dividends & Yields CLGN does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for CLGN is $12,
which is 302.7% higher than the current price. The consensus rating is "Buy".
Price Target $12 Price Target Difference 302.7% Analyst Consensus Buy Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Dec 1, 2016. It was a
backward
split with a ratio of 2:3.
Last Split Date Dec 1, 2016 Split Type backward Split Ratio 2:3
Scores Altman Z-Score -6.77 Piotroski F-Score 2
